1. Differential renal function tests and renography were carried out during infusions oftrimetaphan camsylate (Arfonad, Roche) in twenty-three patients with renovascular hypertension resulting from unilateral obstructive disease of the main renal artery. Renal plasma flow, glomerular filtration rate, urinary volume and sodium excretion were measured. Peak-time and slope index were assessed on renograms. Ten patients underwent revascularization of the kidney; nephrectomy was done in thirteen.
with R VH who were cured or improved by surgery and the changes were severe in at least onehalf of them. Conversely, the contralateral kidney appeared free from disease in 30% of patients who did not benefit from surgery.
Differential renal function studies performed under basal conditions are equally unreliable in the assessment of function of the contralateral kidney. Stamey (1963 Stamey ( , 1966 reported that surgery is contra-indicated when the renal plasma flow (RPF) of the contralateral kidney is less than 200-250 ml/rnin, However, De Mendonca & Young (1967) reported good results from surgery in patients whose contralateral RPF was less than 200-250 ml/rnin and Vertes, Genuth, Leb & Galvin (1965) showed that the RPF measured under basal conditions is not always an adequate index of the anatomical state of the kidney. Maxwell, Lupu & Franklin (1968) pointed out that the RPF of the contralateral kidney was less than 250 nil/min in 30% of patients cured or improved by surgery whereas it was more than 250 ml/rnin in 75% of patients in whom surgery was unsuccessful.
These observations suggest that in some cases the contralateral kidney has a low RPF because of vasoconstriction, whereas in others there is a high RPF as a result of high perfusion pressure despite the presence of severe arteriolar disease.
We thought this hypothesis could be verified by means of a dynamic test with a vasoactive drug. Trimetaphan camsylate was chosen for its ganglion-blocking activity, but mainly to achieve selective renal vasodilatation (McCubbin & Page, 1952; Page & McCubbin, 1953) .
We also thought this study might provide an improved method for predicting the response to surgery and the pre-operative investigations were therefore considered in the light of the surgical results.
MATERIAL AND METHOD
The investigation embraced twenty-three patients with R VH, sixteen males and seven females. Their average age was 41 years, range 23-54 years. Table 1 shows the arterial lesions responsible for hypertension. The diagnosis ofRVH was made by means of angiography, renography, intravenous pyelography and differential renal function studies by using the technique suggested by Stamey (1963) . The Howard test (Connor, Thomas, Haddock & Howard, 1960) was performed in all patients with renal artery stenosis and in one patient with complete occlusion. Patients with renal artery stenosis and a negative Howard test were excluded from the study.
All patients with complete occlusion of the renal artery showed either clear collateral supply on angiography or mild renal pelvis opacification on intravenous pyelography. The basal contralateral renogram was normal in every case.
None of the patients showed clinical evidence of heart or kidney failure and in all BUN, serum creatinine, plasma electrolytes and urinary catecholamines were within the normal range.
Differential renal function studies were performed both under basal conditions and during infusion of trimetaphan camsylate (Arfonad, Roche).
The fasting patient was given 1 litre of water by mouth and 250 ml of 4% (w/v) urea in saline intravenously at a rate of 40 drops/min. The patient was then taken to the cystoscopy room and the infusion was changed to 8% urea in saline containing PAH and inulin in amounts sufficient to maintain a blood concentration just under 3-4 mg of PAH/lOO ml and 20-30 mg of inulin/IOO ml. The solution also contained antidiuretic hormone (5 mU/kg body weight). Immediately before the infusion the patient was given a priming dose of PAH (8 rug/kg) and inulin (50 mg/kg), After medication with analgesic and antispasmodic drugs, ureteric catheters were introduced up to the renal pelvis. The calibre of the catheters was considered important and the largest possible gauge was used.
The start of the clearance period was marked at 30 min after the beginning of the infusion of the 8% urea solution and in every case 15-20 min after the introduction of the ureteric catheters. The clearance periods lasted at least to min each and during every period a blood sample was withdrawn.
Two or three clearance periods having been completed, a drip was started of 250 mg of trimetaphan in 250 ml of saline, which was maintained until the initial systolic BP dropped by 15-20%. The dosage range eventually given was 100-250 mg over a period of time varying from 30 to 60 min. Special care was taken to lower the BP slowly. In patients resistant to the drug no further effort was made to obtain such a decrease of the BP. Patients were considered resistant to trimetaphan if they did not show a prompt decrease in BP during trimetaphan administration at the reported concentration while other symptoms of the action of the drug were present. This occurred in two cases.
The BP was maintained at the decreased value by adjusting the administration of trimetaphan and further clearance estimations were made. In some cases sampling was repeated when arterial blood pressure had returned to the preinfusion value after the trimetaphan drip was discontinued.
To verify the absence ofleakage between the catheters and the walls of the ureters a Nelaton catheter was introduced into the bladder and Methylene Blue was injected into the ureteric catheters.
Urine and serum were analysed for osmolarity (Fiske osmometer), BUN, creatinine, PAH and inulin (autoanalyser techniques) and sodium (flame photometer, Beckmann D.V.). The clearance values were corrected for 1'73 m 2 of body surface. Renography was also performed both under basal conditions and during trimetaphan drip. Tracings were recorded by scintillation detectors with thallium-activated NaI crystals 2 in x 2 in and a wide-angle collimator connected to a ratemeter and a linear graphic recorder. The patient was in the supine position and the position of the scintillation recorders over the kidneys was confirmed by X-ray examination. P 3 1 I]Hippuran (5-8 jlCi) was given intravenously for each recording. The fasting patient was given 250 ml of water by mouth and basal renograms were recorded 30 min afterwards. Subsequently the trimetaphan infusion was started and arterial blood pressure lowered by the same procedure as for differential renal function tests. Further renograms were then recorded. Renal transit time of the radioactive tracer was evaluated by calculating the peak-time and slope of the third component marked on the renogram where the peak radioctivity was decreased to 75%. Measurements from sixty normal subjects are reported in Table I. All twenty-three patients investigated by the above techniques were treated surgically as indicated in Tables 3 and 4 and followed-up closely after operation by means of renography.
A patient was considered cured when his arterial blood pressure was decreased to 140/ 90 mmHg I year after the operation and improved when his blood pressure was lowered to 160/I00 mmHg. In all experiments the differences between the means were tested by Student's t test. 
RESULTS

Response of contralateral kidney to trimetaphan
The control studies of the contralateral kidney by differential renal function tests and renography are reported in Table 2 .
Patients can be divided into two groups according to the response of the contralateral T: during trimetaphan infusion; Ch: change during reduction in pressure; R: revascularization; N: nephrectomy; see Table 1 for remaining abbreviations.\ kidney to trimetaphan. Table 3 shows the functional data and the surgical procedures in patients of group A: mean arterial pressure decreased by approx. 15% after trimetaphan, but RPF increased by 15% (P<O·OOI) and GFR by 10% (P<O·OOI). Urinary volume and excretion of sodium also increased (by 22% and 23% respectively; P<O'OOI) and the renogram remained unchanged. A divergent functional response occurred in patients ofgroup B (Table 4) : mean arterial pressure decreased by 16% after trimetaphan whereas RPF decreased by 39% (P<O'OI), GFR by 32% (P<O·OOI), urinary volume by 55% (P<O'OI) and excretion of sodium by 34% (P<O·OI). Delay of peak-time and slope index was observed on the renogram.
Comparison ofpatients in groups A and B
Under basal conditions there was no significant difference between patients of group A and those of group B for mean arterial pressure (l40± 14·4 and 150± 11·7 mmHg respectively), RPF (276±33 and 276±81'4 ml/min respectively) or GFR (59±1l'6 and 62±14'7 ml/min respectively) ( Table 5) . Urinary volume and excretion of sodium were somewhat higher in group B under basal conditions. Tables 2 and 3. • Change during trimetaphan infusion.
After a similar decrease of mean arterial pressure by trimetaphan in both groups, RPF increased to 317 mljmin in patients of group A whereas it decreased to 169 ml/min in group B; the difference is significant (P<O·OOI) . All other indices studied showed significant variations in the same direction as RPF.
The renogram did not change during trimetaphan infusion in patients of group A but renal transit time increased in group B.
Results of surgery Table 6 shows the results of surgery in the two groups of patients subdivided according to whether a nephrectomy or a reconstructive procedure had been carried out.
All patients of group A were cured of their hypertension. Three reconstructive procedures and three nephrectomies were undertaken in group B. None of three patients treated by nephrectomy benefited from surgery, whereas of the three cases treated by arterial reconstruction one was cured and two were improved. 
DISCUSSION
Differential renal function tests and renography enabled us to divide twenty-three patients with renovascular hypertension (RVH) into two groups according to the functional response of the contralateral kidney during trimetaphan infusion. Patients of group A and B were comparable with regard to age, severity and character of hypertension and measurement of RPF, GFR and renogram under basal conditions (Tables 1 and 5 ). The decrease of arterial pressure in the two groups was also comparable. No decrease of the cardiac output occurs within the limits of the fall in pressure that was achieved (Schenk & Menno, 1961) , and arterial pressure during the infusion remained within the normal range of renal autoregulation. Increases or mild modifications of RPF, GFR, urinary volume and sodium excretion were recorded during trimetaphan administration in patients ofgroup A, and the renogram remained unchanged. The rise of RPF observed by the technique we used must result from arteriolar dilatation in the kidney (Earley & Friedler, 1966) . Under these conditions the vascular bed of the kidney is submitted to the simultaneous effect of decreased arterial pressure, ganglion blockade and the selective renal vasodilating activity of trimetaphan.
The results recorded in patients of group A thus suggest that vasodilatation occurred in the contralateral kidney.
Conversely, RPF, GFR, urinary volume and excretion of sodium were decreased during trimetaphan administration in patients of group B, and delay of peak-time and slope index was observed in the contralateral kidney. Because of the ganglion blockade produced by trimetaphan, lack of vasodilatation cannot be related to activation of renal sympathetic nerve activity caused reflexly by decrease in pressure (Kaneko, Takeda, Ikeda, Tagawa, Ishi, Takabatake & Ueda, 1970) ; on the other hand, the direct action of trimetaphan on the renal vascular bed did not have any effect. RPF decreased at the same time that arterial pressure fell showing a direct pressure-flow relationship which suggests severe disease of the renal arterioles with a consequent failure to dilate.
All patients of group A were relieved of hypertension by surgery (Table 6 ); this suggests that the contralateral kidney did not interfere with decrease of arterial pressure when either nephrectomy or revascularization of the kidney with main artery disease was carried out. Hence it is reasonable to predict that the results of surgery in RVH will be beneficial provided vasodilatation occurs in the contralateral kidney during trimetaphan administration.
In patients of group B nephrectomy was always unsuccessful, whereas of three patients treated by arterial reconstruction one was cured and two were improved (Table 6 ). We recognize that the small numbers do not permit a firm conclusion to be drawn, but our results suggest that the response of arterial pressure to surgery can be affected by the function of the contralateral kidney if it fails to dilate during trimetaphan infusion. Such a kidney is consistently associated with failure of nephrectomy, but reconstructive procedures are affected to a lesser degree.
When there is severe arteriolar disease in the contralateral kidney it is presumably unable to regulate the arterial pressure adequately itself. At present it is uncertain whether the kidney maintains hypertension through the renin-angiotensin system (Hollenberg, Epstein, Basch, Couch, Hickler & Merrill, 1969; or whether it loses its antihypertensive function (Bergstrom, Carlson & Weeks, 1968; Fasciolo, Hickler, Hinman, Meyer, Muirhead, Smeby & Smeby, 1968; Worcel, Meyer, Angeles d'Auriac & Milliez, 1969; Lee, 1969; Weeks, 1969; Lancet, 1970) . It is evident, however, that hypertension can be relieved if the blood supply of the other kidney is restored by surgery (Table 6) . Perhaps under those circumstances the operated kidney exerts its antihypertensive function. Engell (1969) reported a patient who had been treated by revascularization of the kidney with main artery disease, whose hypertension was cured only after contralateral nephrectomy. In a patient of ours who is not reported here because it was impossible to undertake the differential renal function tests, relief from hypertension was obtained by revascularization of the kidney with arterial disease and contralateral nephrectomy carried out 4 months later. These facts suggest that in a few cases the contralateral kidney is so severely affected that its hypertensive activity cannot be compensated by the other kidney.
The above results support the idea that RPF measured under basal conditions is not a reliable index of the anatomical state of the contralateral kidney and cannot be used to predict the results of surgery. In four patients of group A RPF was less than 250 ml/min but rose during trimetaphan administration, whereas in three patients of group B RPF was more than 250 ml/min but decreased under the same stimulus. Renograms recorded during trimetaphan were consistent with the findings of the differential renal function tests: when RPF wasincreased or unchanged the renogram remained normal; when RPF was decreased an increase in transit time was observed.
The changes in RPF and in the renogram during trimetaphan infusion are not necessarily related to the findings obtained under basal conditions and they provide a more accurate index of the anatomical state of contralateral kidney. The implications in predicting the results of surgery in RVH are obvious. Reconstructive procedures and nephrectomy are of equal value in relieving RVH only in patients who respond as in group A. When the contralateral kidney shows a decrease of RPF during infusion of trimetaphan with delay of peak-time and slope index on the renogram, reconstructive procedures may still succeed in correcting hypertension whereas nephrectomy will fail and should not be advised.
